- Home
- PHIO vs NVVE Comparison
PHIO vs NVVE Comparison
Compare PHIO & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- NVVE
- Stock Information
- Founded
- PHIO 2011
- NVVE 1996
- Country
- PHIO United States
- NVVE United States
- Employees
- PHIO N/A
- NVVE N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- PHIO Health Care
- NVVE Energy
- Exchange
- PHIO Nasdaq
- NVVE Nasdaq
- Market Cap
- PHIO 3.4M
- NVVE 2.8M
- IPO Year
- PHIO N/A
- NVVE N/A
- Fundamental
- Price
- PHIO $2.77
- NVVE $2.97
- Analyst Decision
- PHIO Strong Buy
- NVVE
- Analyst Count
- PHIO 1
- NVVE 0
- Target Price
- PHIO $36.00
- NVVE N/A
- AVG Volume (30 Days)
- PHIO 18.5M
- NVVE 22.0K
- Earning Date
- PHIO 11-14-2024
- NVVE 11-12-2024
- Dividend Yield
- PHIO N/A
- NVVE N/A
- EPS Growth
- PHIO N/A
- NVVE N/A
- EPS
- PHIO N/A
- NVVE N/A
- Revenue
- PHIO N/A
- NVVE $5,144,831.00
- Revenue This Year
- PHIO N/A
- NVVE $200.61
- Revenue Next Year
- PHIO N/A
- NVVE $109.43
- P/E Ratio
- PHIO N/A
- NVVE N/A
- Revenue Growth
- PHIO N/A
- NVVE N/A
- 52 Week Low
- PHIO $1.53
- NVVE $2.58
- 52 Week High
- PHIO $10.35
- NVVE $72.70
- Technical
- Relative Strength Index (RSI)
- PHIO 50.99
- NVVE 45.44
- Support Level
- PHIO $2.41
- NVVE $2.58
- Resistance Level
- PHIO $4.53
- NVVE $4.00
- Average True Range (ATR)
- PHIO 0.83
- NVVE 0.33
- MACD
- PHIO 0.12
- NVVE -0.03
- Stochastic Oscillator
- PHIO 14.18
- NVVE 27.46
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.